{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T22:30:32Z","timestamp":1776205832310,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.diabres.2020.108232","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T21:31:33Z","timestamp":1590096693000},"page":"108232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Use of metformin and risk of breast and colorectal cancer"],"prefix":"10.1016","volume":"165","author":[{"given":"Gad","family":"Rennert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hedy S.","family":"Rennert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Gronich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mila","family":"Pinchev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen B.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2020.108232_b0005","first-page":"1785","article-title":"Associations of type 2 diabetes and diabetes treatment with breast cancer risk and mortality: a population-based cohort study among British women","volume":"23","author":"Redaniel","year":"2012","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.diabres.2020.108232_b0010","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/413782","article-title":"The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese","volume":"2012","author":"Hsieh","year":"2012","journal-title":"Exp Diabetes Res"},{"key":"10.1016\/j.diabres.2020.108232_b0015","doi-asserted-by":"crossref","unstructured":"Calip GS, Yu O, Hoskins KF, et al: Associations between diabetes medication use and risk of second breast cancer events and mortality. Cancer Causes Control 2015;26:1065\u201377.","DOI":"10.1007\/s10552-015-0599-z"},{"key":"10.1016\/j.diabres.2020.108232_b0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00592-015-0756-6","article-title":"Association of diabetes and diabetes treatment with incidence of breast cancer","volume":"53","author":"Garc\u00eda-Esquinas","year":"2016","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.diabres.2020.108232_b0025","doi-asserted-by":"crossref","first-page":"46527","DOI":"10.1038\/srep46527","article-title":"Higher risk of colorectal cancer in patients with newly diagnosed diabetes mellitus before the age of colorectal cancer screening initiation","volume":"7","author":"de Kort","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.diabres.2020.108232_b0030","doi-asserted-by":"crossref","first-page":"18456","DOI":"10.18632\/oncotarget.14472","article-title":"2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications","volume":"8","author":"Gonz\u00e1lez","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.diabres.2020.108232_b0035","article-title":"The relationship between diabetes and colorectal cancer prognosis: A meta-analysis based on the cohort studies","volume":"12","author":"Zhu","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diabres.2020.108232_b0040","series-title":"Goodman & Gilman's pharmacological basis of therapeutics","author":"Goodman","year":"2011"},{"key":"10.1016\/j.diabres.2020.108232_b0045","doi-asserted-by":"crossref","first-page":"480","DOI":"10.18632\/aging.100472","article-title":"Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs","volume":"4","author":"Corominas-Faja","year":"2012","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.diabres.2020.108232_b0050","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/mc.22545","article-title":"Protective effect of metformin in an aberrant crypt foci model induced by 1,2-dimethylhydrazine: Modulation of oxidative stress and inflammatory process","volume":"56","author":"Bordini","year":"2017","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.diabres.2020.108232_b0055","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s12094-013-1144-8","article-title":"Effects of metformin on breast cancer cell proliferation, the AMPK pathway and the cell cycle","volume":"16","author":"Hadad","year":"2014","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.diabres.2020.108232_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098207","article-title":"Metformin induces apoptosis and cell cycle arrest mediated by oxidativestress, AMPK and FOXO3a in MCF-7 breast cancer cells","volume":"9","author":"Queiroz","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diabres.2020.108232_b0065","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/srep00362","article-title":"Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells","volume":"2","author":"Song","year":"2012","journal-title":"Sci Rep"},{"key":"10.1016\/j.diabres.2020.108232_b0070","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.4161\/cc.8.13.8814","article-title":"Metformin induces unique biological and molecular responses in triple negative breast cancer cells","volume":"8","author":"Liu","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.diabres.2020.108232_b0075","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4161\/cc.8.6.7933","article-title":"Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro","volume":"8","author":"Alimova","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.diabres.2020.108232_b0080","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1038\/srep05810","article-title":"Reprogramming ovarian and breast cancer cells into non-cancerous cells by low-dose metformin or SN-38 through FOXO3 activation","volume":"4","author":"Hu","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.diabres.2020.108232_b0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108444","article-title":"Mechanisms by which low glucose enhances the cytotoxicity of metformin to cancer cells both in vitro and in vivo","volume":"9","author":"Zhuang","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diabres.2020.108232_b0090","doi-asserted-by":"crossref","unstructured":"Fuentes-Mattei E, Velazquez-Torres G, Phan L, et al. Effects of obesity on transcriptomic changes and cancer hallmarks in estrogen receptor-positive breast cancer. J Natl Cancer Inst 2014;106. pii: dju158.","DOI":"10.1093\/jnci\/dju158"},{"key":"10.1016\/j.diabres.2020.108232_b0095","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12885-015-1235-8","article-title":"In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors","volume":"15","author":"Barbieri","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.diabres.2020.108232_b0100","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4161\/cc.9.1.10407","article-title":"Metformin extends life span of HER-2\/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo","volume":"9","author":"Anisimov","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.diabres.2020.108232_b0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1158\/1055-9965.EPI-10-0817","article-title":"Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark","volume":"20","author":"Bosco","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.diabres.2020.108232_b0110","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1200\/JCO.2011.39.7505","article-title":"Diabetes, metformin, and breast cancer in postmenopausal women","volume":"30","author":"Chlebowski","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.diabres.2020.108232_b0115","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fonc.2016.00210","article-title":"Type 2 Diabetes, Antidiabetic Medications, and Colorectal Cancer Risk: Two Case-Control Studies from Italy and Spain","volume":"6","author":"Rosato","year":"2016","journal-title":"Front Oncol"},{"key":"10.1016\/j.diabres.2020.108232_b0120","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejim.2016.05.027","article-title":"Colon neoplasia in patients with type 2 diabetes on metformin: A meta-analysis","volume":"33","author":"Rokkas","year":"2016","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.diabres.2020.108232_b0125","first-page":"30059","article-title":"Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis","volume":"S1262\u20133636","author":"Tseng","year":"2017","journal-title":"Diabetes Metab pii"},{"key":"10.1016\/j.diabres.2020.108232_b0130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1055\/s-0042-100910","article-title":"Diabetes and Cancer: a Review of Current Knowledge","volume":"124","author":"Wojciechowska","year":"2016","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.diabres.2020.108232_b0135","first-page":"57","article-title":"Metformin in cancer prevention and therapy","volume":"2","author":"Kasznicki","year":"2014","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.diabres.2020.108232_b0140","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/dom.12036","article-title":"Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus","volume":"15","author":"Qiu","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2020.108232_b0145","doi-asserted-by":"crossref","DOI":"10.1158\/1940-6207.CAPR-16-0277","article-title":"No Decreased Risk of Gastrointestinal Cancers in Users of Metformin in The Netherlands; A Time-Varying Analysis of Metformin Exposure","author":"de Jong","year":"2017","journal-title":"Cancer Prev Res (Phila) [Epub ahead of print]"},{"key":"10.1016\/j.diabres.2020.108232_b0150","doi-asserted-by":"crossref","unstructured":"Hong JL, Jonsson Funk M, Buse JB, et al: Comparative Effect of Initiating Metformin Versus Sulfonylureas on Breast Cancer Risk in Older Women. Epidemiology 2017;28:446\u2013454.","DOI":"10.1097\/EDE.0000000000000635"},{"key":"10.1016\/j.diabres.2020.108232_b0155","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10549-015-3307-5","article-title":"Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial","volume":"150","author":"Hadad","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.diabres.2020.108232_b0160","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s10549-012-2223-1","article-title":"Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study","volume":"135","author":"Niraula","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.diabres.2020.108232_b0165","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3109\/07357907.2014.889706","article-title":"Pre-surgical trial of metformin in overweight and obese patients with newly diagnosed breast cancer","volume":"32","author":"Kalinsky","year":"2014","journal-title":"Cancer Invest"},{"key":"10.1016\/j.diabres.2020.108232_b0170","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1200\/JCO.2011.39.3769","article-title":"Dual effect of metformin on breast cancer proliferation in a randomized pre-surgical trial","volume":"30","author":"Bonanni","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.diabres.2020.108232_b0175","series-title":"Metformin sensitizes triple-negative breast cancer to proapoptotic TRAIL receptor agonists by suppressing XIAP expression. Breast Cancer Res Treat [Epub ahead","author":"Strekalova","year":"2017"},{"key":"10.1016\/j.diabres.2020.108232_b0180","doi-asserted-by":"crossref","unstructured":"Meng F, Song L, Wang W. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis. J Diabetes Res 2017;5063239.","DOI":"10.1155\/2017\/5063239"},{"key":"10.1016\/j.diabres.2020.108232_b0185","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5217\/ir.2014.12.2.139","article-title":"Does metformin affect the incidence of colonic polyps and adenomas in patients with type 2 diabetes mellitus?","volume":"12","author":"Cho","year":"2014","journal-title":"Intest Res"},{"key":"10.1016\/j.diabres.2020.108232_b0190","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/jgh.13639","article-title":"Metformin use and the risk of colorectal adenoma: A systematic review and meta-analysis","volume":"32","author":"Jung","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.diabres.2020.108232_b0195","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00384-017-2782-z","article-title":"The effect of metformin on the recurrence of colorectal adenoma in diabetic patients with previous colorectal adenoma","volume":"32","author":"Han","year":"2017","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.diabres.2020.108232_b0200","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1158\/1055-9965.EPI-15-0559","article-title":"Metformin use and risk of colorectal adenoma after polypectomy in patients with type 2 diabetes mellitus","volume":"24","author":"Marks","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.diabres.2020.108232_b0205","doi-asserted-by":"crossref","first-page":"16017","DOI":"10.18632\/oncotarget.13762","article-title":"Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.diabres.2020.108232_b0210","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1056\/NEJMoa043792","article-title":"Statins and the risk of colorectal cancer","volume":"352","author":"Poynter","year":"2005","journal-title":"N Engl J Med"},{"issue":"28","key":"10.1016\/j.diabres.2020.108232_b0215","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1200\/JCO.2010.28.1113","article-title":"Use of bisphosphonates and risk of postmenopausal breast cancer","volume":"2010","author":"Rennert","year":"2010","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.diabres.2020.108232_b0220","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1200\/JCO.2010.33.7485","article-title":"Use of bisphosphonates and reduced risk of colorectal cancer","volume":"29","author":"Rennert","year":"2011","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.diabres.2020.108232_b0225","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1158\/1078-0432.CCR-16-0547","article-title":"Oral Bisphosphonates and Improved Survival of Breast Cancer","volume":"23","author":"Rennert","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.diabres.2020.108232_b0230","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/jnci\/djq042","article-title":"A case-control study of levothyroxine and the risk of colorectal cancer","volume":"102","author":"Rennert","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.diabres.2020.108232_b0235","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/1874288200802010009","article-title":"Validity and Reproducibility of a Semi-quantitative Food Frequency Questionnaire adapted to an Israeli Population","volume":"2","author":"Yizhaki","year":"2008","journal-title":"The Open Nutrition Journal"},{"key":"10.1016\/j.diabres.2020.108232_b0240","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41523-017-0024-8","article-title":"The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk","volume":"3","author":"Slavin","year":"2017","journal-title":"npj Breast Cancer"},{"issue":"5 Suppl","key":"10.1016\/j.diabres.2020.108232_b0245","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/1097-0142(19920901)70:3+<1300::AID-CNCR2820701517>3.0.CO;2-O","article-title":"Colon cancer genetics","volume":"70","author":"Lynch","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.diabres.2020.108232_b0250","doi-asserted-by":"crossref","unstructured":"Kyu HH, Bachman VF, Alexander LT, et al. Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013. BMJ 354:i3857, 2016.","DOI":"10.1136\/bmj.i3857"},{"key":"10.1016\/j.diabres.2020.108232_b0255","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/ijc.29922","article-title":"Fruit and vegetable intakes and risk of colorectal cancer and incident and recurrent adenomas in the PLCO cancer screening trial","volume":"138","author":"Kunzmann","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.diabres.2020.108232_b0260","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-3-642-10858-7_11","article-title":"Physical activity and breast cancer: review of the epidemiologic evidence and biologic mechanisms","volume":"188","author":"Friedenreich","year":"2011","journal-title":"Recent Results Cancer Res"},{"issue":"Suppl 2","key":"10.1016\/j.diabres.2020.108232_b0265","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.breast.2013.07.006","article-title":"Nutrition and physical activity influence on breast cancer incidence and outcome","volume":"22","author":"Chlebowski","year":"2013","journal-title":"Breast"},{"issue":"32","key":"10.1016\/j.diabres.2020.108232_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14320","article-title":"Chemoprevention of colorectal cancer: systematic review and economic evaluation","volume":"14","author":"Cooper","year":"2010","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.diabres.2020.108232_b0275","doi-asserted-by":"crossref","first-page":"40389","DOI":"10.18632\/oncotarget.16315","article-title":"Aspirin as a potential modality for the chemoprevention of breast cancer: A dose-response meta-analysis of cohort studies from 857,831 participants","volume":"8","author":"Lu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.diabres.2020.108232_b0280","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrclinonc.2013.169","article-title":"Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates","volume":"10","author":"Gronich","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.diabres.2020.108232_b0285","doi-asserted-by":"crossref","unstructured":"Heckman-Stoddard BM, Gandini S, Puntoni M, Dunn BK, DeCensi A, Szabo E. Repurposing old drugs to chemoprevention: the case of metformin. Semin Oncol. 6 Feb;43(1):123\u2013133.","DOI":"10.1053\/j.seminoncol.2015.09.009"},{"key":"10.1016\/j.diabres.2020.108232_b0290","doi-asserted-by":"crossref","unstructured":"Tsioulias GJ, Go MF, Rigas B. NSAIDs and Colorectal Cancer Control: Promise and Challenges. Curr Pharmacol Rep. 2015 Oct 1;1(5):295\u2013301.","DOI":"10.1007\/s40495-015-0042-x"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822720304824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822720304824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:11:23Z","timestamp":1759173083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822720304824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":58,"alternative-id":["S0168822720304824"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2020.108232","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of metformin and risk of breast and colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2020.108232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108232"}}